Voice your opinion on congressional bill HR2064-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.

House committee actions Actions

Committee
May. 21 2019	Subcommittee Hearings Held.
Apr. 04 2019	Referred to the Subcommittee on Health.
Apr. 03 2019	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Apr. 03
2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Apr. 03 2019	Introduced in House Introduced in House

House bill HR2064-116

To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.

House bill HR2064-116

To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.

Promote the cause!

Or use this QR code